Chitosan-thiamine pyrophosphate as a novel carrier for siRNA delivery

Pharm Res. 2008 Dec;25(12):2807-14. doi: 10.1007/s11095-008-9648-6. Epub 2008 Jun 18.

Abstract

Purpose: A novel siRNA carrier was formulated between chitosan (CS) and thiamine pyrophosphate (TPP). Their ability to deliver siRNA were evaluated in stable and constitutive EGFP-expressing HepG2 cells.

Methods: CS-TPP was prepared by dissolving CS in TPP solution at a CS:TPP molar ratio of 1.5:1. Complexes of CS-TPP/siRNA were formed at varying weight ratios and characterized using gel electrophoresis. Their morphologies and particle sizes were evaluated, and the transfection efficiency and cytotoxicity of CS-TPP/siRNA complexes were examined in stable and constitutive EGFP-expressing HepG2 cells.

Results: Gel electrophoresis results indicated that binding of CS-TPP and siRNA depended on the molecular weight (MW) and weight ratio of CS, and the particle sizes of CS-TPP/siRNA complexes were in nano-size. The CS-TPP-mediated siRNA silencing of the endogenous EGFP gene occurred maximally with 70-73% efficiency. The CS-TPP/siRNA complex with the lowest MW of CS (20 kDa) at a weight ratio of 80 showed the strongest inhibition of gene expression, which was higher than Lipofectamine 2000. Over 90% the average cell viabilities of the complexes were observed by MTT assay.

Conclusions: This study suggests that CS-TPP is straightforward to prepare, safe and exhibits significantly improved siRNA delivery potential in vitro.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Survival
  • Chitosan / administration & dosage*
  • Drug Carriers
  • Humans
  • RNA, Small Interfering / administration & dosage*
  • RNA, Small Interfering / genetics
  • Thiamine Pyrophosphate / administration & dosage*
  • Transfection

Substances

  • Drug Carriers
  • RNA, Small Interfering
  • Chitosan
  • Thiamine Pyrophosphate